CMS Open Payments · Tool
Intercept Pharma Europe Ltd. vs OMNIlife science, Inc
Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.
A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.
Compare Different Companies
Payment Overview
Intercept Pharma Europe Ltd.
- Total Payments
- $5.9M
- % of Industry
- 0.0%
- Transactions
- 520
- Avg per Transaction
- $11.3K
- Recipients
- 0
- Avg per Recipient
- $0.00
- Payment Types
- 0
- Top Payment Type
- -
OMNIlife science, Inc
- Total Payments
- $5.8M
- % of Industry
- 0.0%
- Transactions
- 865
- Avg per Transaction
- $6.7K
- Recipients
- 829
- Avg per Recipient
- $7.0K
- Payment Types
- 5
- Top Payment Type
- Royalty or License
Highlighted values indicate the higher figure for each metric.
Total payments compared
Intercept Pharma Europe Ltd. vs OMNIlife science, Inc - total reported payments in CMS Open Payments PY2024
General Payment Types Breakdown
Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.
Intercept Pharma Europe Ltd.
No payment type data available.
OMNIlife science, Inc
83.9%
12.1%
1.7%
1.2%
1.2%
Top 5 General-Payment Recipients
This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.
Intercept Pharma Europe Ltd.
No recipient data available.
OMNIlife science, Inc
- 1
Massachusetts General Hospital
$516,007.61 · 6 txns
- 2
STEFAN KREUZER
$333,351.70 · 41 txns
- 3
JAN KOENIG
$232,680.00 · 3 txns
- 4
VASILI KARAS
$121,664.17 · 67 txns
- 5
LINDA SULEIMAN
$120,678.07 · 3 txns
Summary Comparison
| Metric | Intercept Pharma Europe Ltd. | OMNIlife science, Inc |
|---|---|---|
| Total Payments | $5.9M | $5.8M |
| % of Industry Total | 0.0% | 0.0% |
| Transaction Count | 520 | 865 |
| Avg per Transaction | $11.3K | $6.7K |
| Recipient Count | 0 | 829 |
| Avg per Recipient | $0.00 | $7.0K |
| Payment Type Count | 0 | 5 |
| Top Payment Type | - | Royalty or License |
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.